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Background: Follicular growth and atresia are tightly regulated processes, which involve the participation of
endocrine, autocrine and paracrine factors at the cellular level. Prohibitin (PHB) is a multifunctional intracellular
protein playing an important role in the regulation of proliferation, apoptosis and differentiation. Here we examined
the expression of PHB and its regulation by FSH in vitro and studied the role of PHB in the regulation of apoptosis
and steroidogenesis in response to the apoptosis inducer staurosporine (STS) and to FSH, respectively.
Methods: Undifferentiated and differentiated granulosa cells were collected from diethylstilbestrol (DES)- and
equine chronic gonadotropin (eCG)-primed immature rats, respectively and then cultured with various treatments
(FSH, adenovirus infection, STS) according to experimental design. The apoptosis rate, the production of estradiol
and progesterone, and the expression of distinct proteins (PHB, caspase-3, phospho- and total Akt) were assessed.
Results: PHB is anti-apoptotic and its action is dependent on the differentiated state of the granulosa cells. Data
from gain- and loss-of-function experiments demonstrate that PHB inhibited STS-induced caspase-3 cleavage and
apoptosis in undifferentiated granulosa cells, but was ineffective in differentiated cells. In contrast, PHB suppresses
FSH-induced steroidogenesis and this response is evident irrespective of the differentiated state of granulosa cells.
Conclusion: These findings suggest that PHB regulates granulosa cell apoptosis and steroidogenesis in a follicular stage-
dependent manner and that the dysregulation of PHB expression and action may be relevant to ovarian dysfunction.
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The destiny of the growing follicles (ovulation or atresia)
is dependent on the fate of the cells within them (prolifer-
ation, differentiation or apoptosis) and is tightly regulated
by endocrine, autocrine and paracrine factors [1]. During
follicular development, a large number of follicles undergo
atresia, a process tightly controlled by the cross-talk of cell
death and survival signals [1,2]. The dominant follicles
continue to develop to preovulatory stages, producing ap-
preciable amounts of steroid hormones which are critical
for the reproductive cycle and successful ovulation [3,4].* Correspondence: btsang@ohri.ca
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reproduction in any medium, provided the orProhibitin (PHB) is a multifunctional protein highly
conserved in various species, with identical amino acid se-
quences in mouse and rat and only one residue differing
from that in human [5]. It is present in multiple cellular
compartments, including nucleus, mitochondria, plasma
membrane and lipid droplets, as well as in the circulation
[6-10]. The subcellular localization of PHB may contribute
to its diverse functions in the regulation of proliferation,
apoptosis, senescence and differentiation [11-14]. For ex-
ample, mitochondrial PHB facilitates the maintenance of
mitochondrial morphology and stabilizes newly synthe-
sized mitochondrial enzymes [15,16]. Nuclear PHB has
been implicated in the regulation of gene expression by
interacting with various transcriptional factors, such as
E2F, p53 and estrogen receptor α (ERα) [7,17,18].
PHB is widely expressed in the ovary and is anti-apoptotic
during staurosporine (STS)- and ceramide-induced apoptosistd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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known whether PHB performs similar roles during follicu-
lar development. Although recent data indicated that
silencing of PHB induced granulosa cell shape changes
[22] and PHB suppressed steroidogenesis in undifferenti-
ated granulosa cells [23], our knowledge on the role and
contribution of PHB to granulosa cell differentiation is
incomplete.
In this study, we first examined the expression of PHB
and their regulation by FSH in vitro. Using differentiated
and undifferentiated granulosa cells from distinct stages
of follicular development, we compared its responsive-
ness to the apoptosis inducer STS and to FSH, a differ-
entiation inducer, and also examined the role of PHB by
gain- and loss-of function experiments. We also studied
if the roles of PHB in the regulation of apoptosis and
steroidogenesis are follicular stage-dependent.
Materials and methods
Antibodies and reagents
Cell culture media (M199), fetal bovine serum (FBS), peni-
cillin and streptomycin, L-glutamine, sodium pyruvate
and trypsin were purchased from Invitrogen (Burlington,
Canada). HEPES, Hoechst 33258, equine chronic gonado-
tropin (eCG), and diethylstilbestrol (DES) were purchased
from Sigma (St. Louis, MO). Recombinant human FSH
was purchased from National Hormone and Peptide
Program (Harbor-UCLA Medical Center, Torrance, CA).
Anti-caspase-3 antibody (recognizing both intact and
active caspase-3), anti-phospho-Akt (S473) and anti-Akt
antibodies were purchased from Cell signaling (Danvers,
MA), anti-PHB and anti-β-Actin antibodies were from
Abcam (Cambridge, MA). Horseradish peroxidase-
conjugated secondary antibodies and reagents for SDS-
PAGE were supplied by Bio-Rad (Mississauga, Canada).
Enhanced chemiluminescent (ECL) reagent was from
Thermo Fisher Scientific (Rockford, IL). Adenoviral-PHB,
shPHB and their control particles were obtained from
Dr. Winston Thompson (Morehouse School of Medicine,
Atlanta). QIAShredder and RNeasy mini kit were pur-
chased from QIAGEN (Mississauga, Canada). Random
decamer primers were from Ambion (Austin, TX). Ribo-
nuclease inhibitor and dNTP were from Fermentas
(Burlington, Canada). Moloney murine leukemia virus
reverse transcriptase was from Promega (Madison, WI).
PCR primers were from Invitrogen. All chemical inhibi-
tors were purchased from Calbiochem (Gibbstown, NJ).
All other chemicals were of the highest analytical grade
available from Sigma.
Animal preparation
Twenty one days old Sprague–Dawley rats (Charles
River, Montreal, Canada) were maintained on 12-h light,
12-h dark cycles and given food and water ad libitum.All procedures were carried out in accordance with the
Guidelines for the Care and Use of Laboratory Animals,
Canadian Council on Animal Care, and were approved
by the University of Ottawa and the Ottawa Hospital Re-
search Institute Animal Care Committee.
Primary culture of rat granulosa cells and adenoviral
infection
Granulosa cells from eCG-primed immature rats (10 IU,
48h, s.c.; considered as differentiated granulosa cells) and
DES-injected control rats (1 mg/day for 3 consecutive
days, s.c.; considered as undifferentiated granulosa cells)
were pre-incubated with 6 mM EGTA and 0.5 M sucrose
[24] and were released by follicular puncture with a 26.5-
gauge needle, washed and centrifuged (900 × g, 5 min).
Cell clumps and oocytes were removed by filtering the cell
suspensions through a 40-μm nylon cell strainer (BD Bio-
sciences). The viability of granulosa cells was determined
by trypan blue exclusion. Granulosa cells (0.9 × 106 per
well in 6-well plate) were plated overnight in M199 with
10% FBS under a humidified atmosphere of 95% air and
5% CO2. After culture overnight in serum-free medium,
granulosa cells were treated with FSH (0–200 ng/ml) or
STS (1 μM) for a designated duration.
For adenoviral infection, granulosa cells were cultured
in serum-free M199 medium containing adenoviral parti-
cles for 24 h followed by medium change. Multiplicity of
infection (MOI) and duration of infection are detailed in
the figures. Equal amounts of adenovirus in each experi-
mental group were achieved by adjusting with an appro-
priate amount of adenoviral-LacZ (negative control for
adenoviral-PHB) or adenoviral-shNeg (negative control
for shPHB).
RT-PCR
Total RNA of granulosa cells was extracted according
to the manufacturer’s instruction, using the QIAGEN
RNeasy Mini kit. Two hundred ng total RNA were
used to reverse transcribe cDNAs and the mRNA abun-
dance of target genes was analyzed by PCR. The PHB
primers used for amplification were a 50 forward primer (50-
TGGCAGCCTGAGTAGACCTT-30) and a 30 reverse pri-
mer (50-TCACGGTTAAGAGGGAATGG-30). The p450scc
primers were a 50 forward primer (50-ACCCTGAGTCCCA
GCGGTTC-30) and a 30 reverse primer (50-CACCCC-
TCCTGCCAGCATCT-30). The aromatase primers were a
50 forward primer (50-TGGTCCCG-GAAACTGTGCCT-
30) and a 30 reverse primer (50-CCACGCTTGCTGCCG
AATCT-30). The actin primer were (50-CGTCCACCCGCG
AGTACAAC-30) and a 30 reverse primer (50- GCCT-
CTCTTGCTCTGGGCCT-30). The thermal cycling condi-
tions were comprised of an initial denaturation step at 95 C
for 10 min followed by 30 cycles amplification for PHB,
p450scc and aromatase (20 cycles for actin) at 95 C for
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ucts were subjected to 2% ethidium bromide-containing
agarose gel and visualized under UV light.
Protein extraction and western blot
At the end of the culture period, floating cells and attached
cells (recovered by 0.05% trypsin treatment) were pooled
and centrifuged (1000 × g, 10 min). For protein extraction,
cell pellets were resuspended in a lysis buffer (PBS, pH 7.4)
containing NaCl (150 mM), SDS (0.1%), sodium deo-
xycholate (0.5%), Nonidet P-40 (1%), and the protease in-
hibitor cocktail (Sigma) and kept on ice for 30 min. Cell
lysates were sonicated and centrifuged (12,000 × g, 5 min,
4°C) to remove insoluble material. Supernatant was reco-
vered and stored at −20°C until further processing. Protein
concentrations in each sample were determined by the
Bradford assay (Bio-Rad Laboratories). Twenty μg of pro-
tein of cell lysates were subjected to SDS-PAGE with 4.5%
stacking and 15% separating gels. Proteins were electro-
phoretically transferred onto nitrocellular membrane (NC,
Bio-Rad), blocked at room temperature with 5% skim milk
in TBST [0.05% Tween-20 in Tris (10 mM) and NaCl
(0.15 M), pH7.4 (TBS)] for 1 h and then incubated over-
night at 4°C with diluted primary antibodies (1:1000) in
TBST with constant agitation. The membranes were then
treated with a secondary antibody (1:2000 to 1:10,000 based
on different primary antibody). After washing three times
with TBST, immunoreactive bands were visualized with
ECL according to the manufacturer’s instruction. Intensity
of bands of the exposed X-ray film was determined by
densitometrically scanned, quantified, using AlphaEaseFC
(Alpha Innotech, CA) and normalized with β-Actin.
Assessment of apoptosis
Apoptotic cells were identified morphologically by
Hoechst-33258 (bisBenzimide, Sigma) staining as previ-
ously reported [25]. At the end of the culture period,
suspended cells were collected by centrifugation and
attached cells were trypsinized. The two cell fractions
were then pooled, pelleted, and suspended in 10%
phosphate-buffered formalin containing Hoechst 33258
(6.25 μg/ml; room temperature, 2 h), Cells were then
spotted on slides and assessed for typical apoptotic nu-
clear morphology. To quantify the number of apoptotic
cells, healthy and apoptotic cells were counted (counter
was “blinded to sample identity”) and the apoptotic cells
were expressed as a percentage of total cells. A mini-
mum of 400 cells were counted in each treatment group.
Steroids secretion analysis
Spent medium from granulosa cell cultures were col-
lected, centrifuged (900 × g, 5 min) and kept in −80°C for
hormone analysis. 17β-estradiol and progesterone concen-
trations in spent medium were measured using enzymeimmunoassay kit (EIA; Enzo Life Sciences, Farmingdale,
NY) according to the manufacturer’s instruction. The
detection limitation of estradiol was 28 pg/ml, and the
intra- and inter-assay coefficients of variation were 8 and
6%, respectively. The detection limitation of progesterone
was 8.5 pg/ml, and the intra- and inter-assay coefficients
of variation were 7 and 6%, respectively.
Statistical analysis
All data were analyzed using GraphPad Prism 5.0 statis-
tical software (San Diego, CA). Results are expressed as
mean ± SEM of at least three independent experiments as
detailed in the figures. One-way and two-way ANOVA
were used to assess the effects and interactions of one or
two variables and multiple comparisons were achieved by
a Bonferroni post hoc test. Significant difference was de-
fined at p < 0.05 (*, or #).
Results
PHB is differentially expressed in granulosa cells from
different follicular stages
To examine whether PHB is expressed in vivo in a fol-
licular stage-dependent manner, differentiated and
undifferentiated granulosa cells were collected and the
gene expression of PHB was analyzed by traditional
PCR. As shown in Figure 1A, differentiated granulosa cells
exhibited increased expression of p450scc and aromatase,
steroidogenic enzymes known to be associated with gra-
nulosa cell differentiation. The PHB expression in differen-
tiated granulosa cells was lower than that in undifferentiated
granulosa cells.
FSH upregulates PHB content in differentiated but not
undifferentiated granulosa cells
To explore whether FSH regulates PHB expression
in vitro, undifferentiated and differentiated granulosa cells
were cultured with FSH (100 ng/ml) for designated time
(0–24 h) and the contents of PHB in two types of cells
were examined. As shown in Figure 1B, FSH had no effect
on PHB content in undifferentiated granulosa cells (p >
0.05). In the contrast, FSH up-regulated PHB expression
in differentiated granulosa cells (p < 0.001). While there
was an apparent gradual increase in PHB content with the
duration of culture in the presence of FSH, significant
upregulation was not evident until 24 h. Both undifferenti-
ated (p < 0.0001) and differentiated (p < 0.001) granulosa
cells exhibited a rapid increase in phosphorylated Akt
content; however, Akt activation in the former was stron-
ger (6-fold vs. 2-fold change at 0.25h) and sustained longer
(over basal level at 4-8h) compared with that in the latter.
We then examined whether FSH regulates PHB contents
in differentiated granulosa cells in a concentration-dependent
manner. Undifferentiated and differentiated granulosa cells
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Figure 1 The regulation of PHB by gonadotropin. (A) Total RNAs of undifferentiated and differentiated granulosa cells were extracted and
mRNA abundance of PHB was analyzed by PCR. p450scc and aromatase mRNA levels were assessed as differentiated marker and Actin was used
as loading control. (B) Undifferentiated and differentiated granulosa cells were cultured with FSH (100 ng/ml) for designated time period and the
contents of PHB, pAkt and total Akt were examined by Western blot. (C) Undifferentiated and differentiated granulosa cells were cultured with
FSH (0–200 ng/ml) for 24 h. PHB, pAkt and total Akt contents were examined by Western blot. Representative immunoblots are shown and data
are presented as mean ± SEM of three independent experiments. B-C, one-way ANOVA, followed by Bonferroni test. *, p < 0.05; **, p < 0.01; ***,
p < 0.001 (compared with FSH = 0 or FSH at 0 h).
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examined. As shown in Figure 1C, FSH had no effect on
PHB content in undifferentiated granulosa cells (p > 0.05);
however FSH significantly up-regulated the content of
PHB (p < 0.001) at a concentration range of 10–100 ng/ml
in differentiated granulosa cells. There was no significant
difference between the FSH (200 ng/ml) and the control
groups. Since we have reported that Akt and PHB could
regulate each other [23], we also assessed the phosphory-
lated and total Akt levels in this experiment. As shown in
Figure 1C, although there was a trend of decrease, FSH
didn’t significantly reduce Akt phosphorylation in un-
differentiated granulosa cells (p > 0.05). In the contrast,
phosphorylated Akt levels in granulosa cells in differen-
tiated granulosa cells decreased in the presence of FSH
(Figure 1C, p < 0.05), which was reversely related to PHB
contents.
Exogenous PHB suppresses staurosporine-induced
caspase-3 cleavage and apoptosis in undifferentiated, but
not differentiated, granulosa cells
Although PHB has been reported to be anti-apoptotic in
undifferentiated granulosa cells [19,20], whether it plays
a similar role in granulosa cells after differentiation is
not known. To address this question, comparison expe-
riments were performed using undifferentiated andA B










Figure 2 Effect of exogenous PHB on STS-induced caspase-3 cleavage
cells were infected with adenoviral-PHB (MOI = 40, adenoviral-lacZ as contr
cleaved, intact caspase-3 and PHB were examined by Western blot and the
morphology (Hoechst staining). Data are presented as mean ± SEM of three
subsequently by Bonferroni post hoc test. **, p < 0.01 (compared with LacZdifferentiated granulosa cells. Granulosa cells were in-
fected with adenoviral-PHB (MOI = 40, adenoviral-LacZ
as control, 24 h) to over-express or knockdown PHB,
and then cultured with the apoptosis inducer staurosporine
(STS, 1 μM, 2 h). As shown in Figure 2A, whereas PHB
over-expression had no effect on basal level of apoptosis in
undifferentiated granulosa cells, it suppressed STS-induced
caspase-3 cleavage (Figure 2A, PHB, p < 0.05; STS, p <
0.0001; PHB × STS, p < 0.05) and apoptosis (PHB, p < 0.05;
STS, p < 0.0001; PHB × STS, p < 0.05). In contrast, over-
expression of PHB in differentiated granulosa cells had no
obvious effect on STS-induced caspase-3 cleavage and
apoptosis (Figure 2B), suggesting that PHB is anti-
apoptotic during preantral follicular growth but this prop-
erty is lost as the cells differentiate during follicle transition
into the antral stage.
Knockdown of PHB increases staurosporine-induced
caspase-3 cleavage and apoptosis in undifferentiated, but
not differentiated, granulosa cells
Similar experiments were performed using adenoviral-
shRNA to knockdown PHB in granulosa cells derived
from two preparations. As shown in Figure 3, STS-
induced caspase-3 cleavage and apoptosis were enhanced
after knockdown of PHB in undifferentiated granulosa
cells (Figure 3A, for cleaved caspase-3, shPHB, p < 0.01;CTL STS
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ol) for 24 h and then cultured with STS (1 μM, 2 h). The contents of
apoptosis rate of granulosa cells were assessed by nuclear
independent experiments and analyzed by two-way ANOVA and
). NS: not significant.

















Figure 3 Effect of PHB knockdown on STS-induced caspase-3 cleavage and apoptosis. Undifferentiated (A) and differentiated (B) granulosa
cells were infected with adenoviral-shPHB (MOI = 10, adenoviral-shNeg as control) for 48 h and then cultured with STS (1μM, 2 h). The contents of
cleaved, intact caspase-3 and PHB were examined by Western blot and the apoptosis rate of granulosa cells were assessed by nuclear
morphology (Hoechst staining). Data are presented as mean ± SEM of three independent experiments and analyzed by two-way ANOVA and
subsequently by Bonferroni post hoc test. **, p < 0.01 (compared with LacZ). NS: not significant.
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shPHB, p < 0.01; STS, p < 0.0001; shPHB × STS, p < 0.05).
However, there was no effect of PHB knockdown on STS-
induced caspase-3 cleavage and apoptosis in differentiated
granulosa cells (Figure 3B).
Differentiated granulosa cells are more responsive to FSH
in steroids production compared with undifferentiated
granulosa cells
We have previously reported that PHB suppressed FSH-
induced estradiol and progesterone secretion and p450scc/
aromatase expression in undifferentiated granulosa cells
[23]. As the regulatory role of PHB in granulosa cell apop-
tosis is dependent on the state of cellular differentiation,
we then examined whether it regulate steroidogenesis dif-
ferently in differentiated granulosa cells by comparing the
steroidogenic responsiveness of granulosa cells at the two
differentiative states. Undifferentiated and differentiated
granulosa cells from two preparations were cultured with
FSH (0–100 ng/ml) ± testosterone (T, 0.5 μM, 24 h), which
served as a substrate of aromatase, and then the levels of
estradiol and progesterone in spent medium were mea-
sured. We have previously demonstrated that T enhanced
FSH-induced progesterone and estradiol secretion in un-
differentiated granulosa cells [23]. We observed that FSH-
induced progesterone production in these cells was dra-
matically increased in the presence of T (5.49 ± 0.4 vs. 0.63
± 0.13 ng/ml) and the estradiol secretion exhibited similareffect (48.7 ± 5.7 vs. 0.91 ± 0.16 ng/ml). We concomitantly
tested the effect of T and FSH on differentiated cells
(Figure 4A) and observed that T also enhanced FSH-
stimulated progesterone (7.79 ± 0.63 vs. 1.22 ± 0.98 ng/ml)
and estradiol secretion (94.4 ± 10.23 vs. 0.88 ± 0.14 ng/ml)
in differentiated granulosa cells (Figure 4A, for progester-
one: FSH, p < 0.001; T, p < 0.001; FSH ×T, p < 0.001. for
estradiol: FSH, p < 0.001; T, p < 0.001; FSH ×T, p < 0.001).
The basal levels of estradiol and progesterone at the two
cellular differentiative states were similar; however produc-
tion of these steroids in the presence of FSH and T was
about 2-fold higher in differentiated granulosa cells than in
undifferentiated granulosa cells.
PHB suppresses FSH-induced steroid production in both
undifferentiated and differentiated granulosa cells
Next we examined whether PHB suppresses FSH-induced
steroidogenesis in granulosa cells and if its response is
dependent on the differentiated state of the cells.
Granulosa cells from two preparations were infected with
adenoviral-PHB (adenoviral-LacZ as control) and then
cultured with FSH (0–100 ng/ml) in the presence of T
(0.5 μM) for 24h. The levels of estradiol and progesterone
in spent medium were measured by EIA. Exogenous PHB
suppressed FSH-induced steroid production and the ex-
pression of steroidogenic enzymes p450scc and aromatase
in undifferentiated granulosa cells [23]. FSH-induced pro-
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Figure 4 Influence of PHB on FSH-induced steroid production. (A) Differentiated granulosa cells were cultured with FSH (100 ng/ml) ± T
(0.5 μM) for 24 h and the levels of progesterone and estradiol in the spent medium were measured by EIA. Data are presented as mean ± SEM of
four independent experiments and analyzed by two-way ANOVA and subsequently by Bonferroni post hoc test. ***, p < 0.001 (compared with LacZ).
(B-C) Differentiated granulosa cells were infected with adenoviral-PHB (MOI = 40, adenoviral-LacZ as control) for 24 h and then cultured with FSH
(100 ng/ml, 24 h) in the presence of T (0.5 μM). Progesterone and estradiol in the spent medium (B) were measured by EIA. Data are presented as
mean ± SEM of four independent experiments and analyzed by two-way ANOVA and subsequently by Bonferroni post hoc test. **, p < 0.01; ***,
p < 0.001 (compared with CTL). (C) The expression of p450scc and aromatase was examined by Western blot. Representative immunoblots from
three replicate experiments are shown.
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ng/ml) and the estradiol secretion exhibited similar effect
(55.6 ± 5.0 vs. 21.76 ± 7.72 ng/ml). Concomitant studies
with differentiated granulosa cells indicate that PHB simi-
larly inhibited FSH-induced progesterone (7.70 ± 0.52 vs.
4.70 ± 0.78 ng/ml) and estradiol (95.56 ± 11.17 vs. 48.96 ±
6.7 ng/ml) secretion (Figure 4B, for progesterone: PHB,
p < 0.01; FSH, p < 0.001; PHB × FSH, p < 0.01. for estradiol:
PHB, p < 0.05; FSH, p < 0.001; PHB × FSH, p < 0.05)
in vitro. The contents of p450scc and aromatase induced
by FSH were also suppressed by PHB (Figure 4C).
Discussion
In the present study, we have demonstrated the distinct
roles of PHB in STS-induced apoptosis and FSH-
induced steroidogenesis in granulosa cells at different
stages of follicular development and thus at different cel-
lular differentiative states. FSH regulates PHB expressionin differentiated but not undifferentiated granulosa cells
in vitro. PHB is anti-apoptotic and a suppressor of ste-
roidogenesis in undifferentiated granulosa cells, while it
loses its role in regulating apoptosis but maintains its
latter action as the cells differentiate. These findings
suggest that suppressive roles of PHB in apoptosis and
steroidogenesis are precisely regulated in a follicular
stage-dependent manner. The role of PHB in the regula-
tion of apoptosis, steroidogenesis as well as proliferation
[11,12], the dysregulation of ovarian follicular growth and
steroidogenesis in polycystic ovarian syndrome (PCOS)
[26-28], together with the observations that the expression
of PHB increased in a chronically androgenized rat PCOS
model [23] suggest a possibility that dysregulation of PHB
may be relevant to the etiology of this syndrome.
The main observation in present study is that the anti-
apoptotic action of PHB is evidenced at the preantral
follicle stage of development, one often referred to as
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(continued growth versus atresia) is determined. This ob-
servation also raise the interesting possibility that PHB
may play an important role in deciding the fate of the
granulosa cells as the follicles transition from the preantral
to early antral stage. With regard to the regulation of
apoptosis, PHB may execute its anti-apoptotic role by
down-regulating caspase-3 cleavage and inhibiting cyto-
chrome c release from mitochondria [20]. The loss of
inhibition on apoptosis in differentiated granulosa cells
may due to increased X-linked inhibitor of apoptosis pro-
tein (XIAP) expression and elevated Akt phosphorylation
in these cells [29] known to inhibit apoptosis, which may
modulate the action of PHB. However, we cannot rule out
the possibility that PHB inhibits apoptosis via regulating
the activity of transcriptional factors involved in apoptosis,
as demonstrated by Fusaro et al. that PHB protects cancer
cells from camptothecin-induced apoptosis via suppress-
ing E2F1-mediated transcriptional activity [30]. While the
different transcriptional factors targeted by PHB may
switch off its anti-apoptotic function, this hypothesis
needs further investigation.
In contrast, the participation of PHB in the control of
steroidogenesis in both undifferentiated and differentiated
granulosa cells is consistent with important intraovarian
regulatory role of steroids during follicular development
and the involvement of PHB in the control of the ste-
roidogenic processes. The mechanism by which PHB acts
as a steroidogenesis-suppressor or anti-apoptotic factor
during follicular development and the physiological signal
that drives these responses are unknown. PHB is shown to
be regulated by the novel adipokine chemerin in vitro and
it mediates the suppressive role of chemerin on FSH-
induced steroidogenic enzyme expression in undifferenti-
ated granulosa cells [23]. Because PHB is a co-activator or
co-repressor of distinct transcriptional factors (p53, E2F,
ERα) [7,17,18] and we have observed an interaction of
PHB and NR5a1/2 in freshly isolated rat granulosa cells
(Additional file 1: Figure S1), it is possible that PHB
suppresses steroidogenesis via acting as a co-repressor of
transcriptional factors targeting steroidogenic enzymes,
such as nuclear receptors NR5a1/NR5a2, C/EBP [31-34].
Further studies on promoter activity, DNA mutagenesis
and protein-protein interaction assay are needed to test
this possibility. However, we cannot rule out the possibil-
ity that PHB may regulate the mRNA expression of FSH
receptor.
Besides PHB, other proteins have also been reported to
be differentially regulated and play various functions in
ovarian cells from different follicular stages. Plasminogen
activator plays a crucial role in the dynamic tissue remode-
ling during follicular development and ovulation [35,36]. Its
activity is increased by FSH, and inhibited by transforming
growth factor α, in undifferentiated granulosa cells butdecreased in differentiated ones [37,38]. Another example
is C-type natriuretic peptide (CNP), which binds to its
receptor and promotes preantral follicle growth via stimu-
lating the cGMP release in undifferentiated granulosa
cells; however CNP is unable to increase cGMP level in
differentiated granulosa cells [39]. The cell differentiation-
dependent regulation of intra-ovarian and intracellular
factors may facilitate the precise control of granulosa cell
fate and function during follicular development.
Although the functions of PHB are reported to regulate
many cellular processes in various cell types, how its ex-
pression is regulated is largely unknown. The regulation
of PHB by gonadotropin in the literature is controversial.
We demonstrated that gonadotropin in vivo reduced PHB
mRNA abundance; however others reported that PHB
mRNA levels and protein contents are not altered [40] or
higher after gonadotropin treatment [21]. While the rea-
sons for these apparent differences are not immediately
clear, whether differences in the dosages of gonadotropin
used and/or in the methods of granulosa cell isolation
could account for the different outcome, remains to be de-
termined. In this context, our results also indicated that
high concentration of FSH (200 ng/ml) failed to increase
PHB expression in vitro whereas lower concentration did
(Figure 1C). The effect of high doses of FSH or other mol-
ecules on gene expression has been well documented and
an effective negative feedback mechanism to precisely
control gene expression may be operational. FSH receptor
is desensitized and down-regulated by long exposure of
high dose of FSH [41-43], accompanied by reduced cyp19
expression and estradiol production in granulosa cells
[43]. In addition, anti-Müllerian hormone, known to in-
hibit FSH-induced aromatase expression, is also up-
regulated by low but down-regulated by high dose of
FSH [43]. Low dose of AMH stimulates inhibin B level
in human granulosa cells while the opposite was true
with higher dosages [44].
The mechanism by which FSH regulates PHB expres-
sion is unclear. It is known that FSH acts through multiple
signaling pathways, including cAMP/PKA, PI3K/Akt and
MAPK, and via various transcriptional factors, such as
forkhead box O1, cAMP regulatory element binding pro-
tein and specific protein 1 (Sp1) [45-48]. In addition to pu-
tative binding sites for CCAAT/enhancer-binding protein
(C/EBP) and insulin response element in the promoter of
PHB [49], there are other DNA binding elements such as
E2F, GATA, ER and Sp1 as predicted by the transcription
element search system. It is possible that the transcription
factors maintaining PHB expression in undifferentiated
granulosa cells is switched to others in differentiated
granulosa cells due to the distinct cellular contents. How-
ever, the particular transcription factor involved in the
regulation of PHB in granulosa cells at the two stages of
cellular differentiation needs to be further investigated.
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lation in ovarian cells [45]. Our present studies extent
these findings and show that the rapid increase of phos-
phorylated Akt content in response to FSH is dependent
on the state of cellular differentiation. Since the phosphor-
ylated Akt content is a consequence of both kinase and
phosphatase activities [50], it was of interest to determine
whether this signal is removed with a different efficiency
between different state of differentiation and whether the
decreased pAkt levels are correlated with increased PHB
contents. Our results indicated that the efficiency at which
the PI3K-Akt signaling pathway is turned on and off by
FSH is also dependent on the state of cellular differenti-
ation and may be related to the action of PHB. The re-
verse correlation of PHB and pAkt content was supported
by a recent finding that PHB and Akt could regulate the
expression of each other [23].
In our culture system, both undifferentiated and diffe-
rentiated granulosa cells exhibited a robust steroidogenic
response to FSH. Basal and FSH-induced estradiol secre-
tion in undifferentiated granulosa cells were lower than
those in differentiated granulosa cells in the presence of
testosterone, which could be due to higher basal levels of
p450scc and aromatase induced by gonadotropin with in-
creased granulosa cell differentiation (this study, [51]).
Testosterone was added in the culture as the substrate of
aromatase, which is commonly used in the studies on
FSH-induced estrogen production [45,52,53]. It is also
possible that testosterone not only acted as a substrate in
granulosa cells, but also augmented the action of FSH on
the production of progesterone and estradiol [52,54,55].
Conclusion
Our findings demonstrate that PHB expression is regu-
lated by FSH in a follicular stage-dependent manner
in vitro and the roles of PHB as an anti-apoptotic factor
and in the regulation of steroidogenesis are dependent
on the differentiation status of granulosa cells. It is an
inhibitor of steroidogenesis in both undifferentiated and
differentiated granulosa cells, but is anti-apoptotic in un-
differentiated granulosa cells. This study significantly im-
proves our understanding of the role of PHB in the
ovary although the mechanism by which PHB suppresses
apoptosis and steroidogenesis and the factors involved in
the regulation of PHB remains to be investigated.
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Additional file 1: Figure S1. Interaction of PHB and NR5a1/2.
Granulosa cells were collected from eCG-primed rats and then lyzed in IP
lysis buffer. Endogenous PHB in 500 μg cell lysate was
immunoprecipitated with 2 μg mouse anti-PHB antibody (normal mouse
IgG as control), subjected to 15% SDS-PAGE and probed with the
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